imatinib mesylate has been researched along with Dermatitis, Contact, Phototoxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, NS; Dassanayake, S; Mealey, KL | 1 |
| An, R; Hagiya, Y; Hoshijima, K; Ishikawa, T; Mikuriya, K; Tamura, A; Yoshida, T | 1 |
1 review(s) available for imatinib mesylate and Dermatitis, Contact, Phototoxic
| Article | Year |
|---|---|
Drug-induced phototoxicity evoked by inhibition of human ABC transporter ABCG2: development of in vitro high-speed screening systems.
Topics: Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Dermatitis, Phototoxic; Fluoroquinolones; Humans; Imatinib Mesylate; Neoplasm Proteins; Photochemotherapy; Piperazines; Polymorphism, Genetic; Porphyrins; Pyrimidines | 2008 |
1 other study(ies) available for imatinib mesylate and Dermatitis, Contact, Phototoxic
| Article | Year |
|---|---|
Tyrosine kinase inhibitors enhance ciprofloxacin-induced phototoxicity by inhibiting ABCG2.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blotting, Western; Ciprofloxacin; Dermatitis, Phototoxic; Drug Synergism; Flow Cytometry; Gefitinib; Gene Expression Regulation; HEK293 Cells; Humans; Imatinib Mesylate; Neoplasm Proteins; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Risk Factors | 2014 |